Betel Chewing and Arecoline Affects Eotaxin-1, Asthma and Lung Function by Wang, Tsu-Nai et al.
Betel Chewing and Arecoline Affects Eotaxin-1, Asthma
and Lung Function
Tsu-Nai Wang1,2, Ming-Shyan Huang2,3, Meng-Chih Lin4, Tsai-Hui Duh2,5, Chih-Hung Lee6, Chin-
Chou Wang4, Ping-Ho Chen2,7, Shang-Lun Chiang8,9, Chau-Chyun Sheu10, Vincent Chin-Hung Chen11,13,
Chao-Chien Wu4.*, Cleusa P. Ferri12, Robert Stewart13, Ying-Chin Ko8,9.*
1Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan, 2Center of Excellence for Environmental Medicine,
Kaohsiung Medical University, Kaohsiung, Taiwan, 3Division of Pulmonary and Critical Care Medicine and Geriatric Medicine, Department of Internal Medicine, Kaohsiung
Medical University Hospital, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 4Division of Pulmonary and Critical Care Medicine, Department of
Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 5Department of Medicinal and
Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan, 6Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung
University College of Medicine, Kaohsiung, Taiwan, 7 School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 8 Environment-
Omics-Diseases Research Center, China Medical University Hospital, Taichung, Taiwan, 9Graduate Institute of Clinical Medical Science, China Medical University, Taichung,
Taiwan, 10Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Faculty of Medicine, College of
Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 11Department of Psychiatry, School of Medicine, Institute of Medicine, Chung Shan Medical University, The
Department of Psychiatry, Chung Shan Medical University Hospital, Taichung. Taiwan, 12Universidade Federal de Sa˜o Paulo – Psychobiology Department, Sa˜o Paulo,
Brazil, 13 King’s College London, Institute of Psychiatry, London, United Kingdom
Abstract
Background: Betel nut is commonly used in many countries. Despite evidence suggesting an association with asthma, few
studies have investigated the connection between betel nut use and asthma; thus, the underlying mechanism for the
association with asthma is also unclear. The aim of this study was to investigate the association between betel chewing and
asthma as well as the associations of plasma arecoline (a biomarker for exposure) and eotaxin-1 (a potential mediator) with
asthma and lung function.
Methods: We recruited 600 hospital-based asthmatic patients and 1200 age- and gender-matched community controls in
southern Taiwan. To clarify the mechanism of action for eotaxin-1 in the association between betel chewing and asthma, we
also designed an in vitro experiment to study the functional associations between arecoline exposure and eotaxin-1 levels.
Results: A significant association was found between asthma and current betel chewing (adjusted odds ratio 2.05, 95%
CI = 1.12–3.76), which was independent of potential confounders but was attenuated following adjustment for eotaxin-1.
Arecoline and eotaxin-1 levels were positively correlated (Spearman r = 0.303, p = 0.02), while arecoline and arecaidine were
negatively correlated with lung function. Functionally, arecoline alone does not induce eotaxin-1 release in vitro from
dermal and gingival fibroblasts. However, in the presence of IL-4 and TNF-alpha, arecoline at 100 mg/ml induced more
eotaxin-1 release than arecoline at 0 mg/ml (2700698 pg/ml vs 18506142 pg/ml, p = 0.01 in dermal fibroblast cells, and
1489678 pg/ml vs 1044695 pg/ml, p = 0.03 in gingival fibroblast cells, respectively).
Conclusion: Betel chewing is associated with asthma in this population, with arecoline induction of eotaxin-1 supported as
a plausible causal pathway.
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Introduction
Betel nut is a common substance used by an estimated 600
million people worldwide [1], particularly in India, the South
Pacific Islands and Southeast Asia. Betel nut is also widely used in
Asian migrant populations in the USA [2], UK and Europe [3].
Arecoline, a cholinergic alkaloid, constitutes 0.15–0.67% of the
dry weight of betel quid and has been found to be associated with a
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variety of outcomes, including esophageal cancer, cardiovascular
disease, diabetes, and asthma [4-6]. Betel quid chewing is also
well-recognized as an independent risk factor for oral cancers
[7,3]. The main alkaloids contained in areca nut are arecoline and
arecaidine, which have been supported as exposure biomarkers for
a the habit of betel chewing [8].
Considering the widespread exposure and potential risk, few
studies have investigated the relationship between betel chewing
and asthma. Kiyingi found that 11 of 20 asthmatic patients who
had ceased betel chewing reported stopping because of aggrava-
tion of asthma symptoms. Of 34 patients who still chewed, 22 also
reported asthma attacks precipitated by betel chewing [9]. Taylor
et al. reported that two patients hospitalized with asthma had been
chewing betel nut immediately before the attacks, and they also
performed a double-blind challenge test of arecoline inhalation,
which was found to cause bronchoconstriction in six of seven
people with asthma and one of six healthy controls [10]. However,
not all studies have found this reaction [11].
Table 1. Characteristics of the case and control participants.
Asthma cases (n =600) Community controls (n=1200) p-value
Male/female 255/345 510/690 1.00
Mean (SD) age 52.49614.55 51.98613.08 0.47
Mean (SD) IgE (U/ml) 259.06609.5 122.56289.0 ,0.001
Mean (SD) BMI (kg/m2) 25.6664.20 23.7663.51 ,0.001
Asthma symptoms
Mean (SD) age at first diagnosis6SD 44.92618.22 -
In the past 12 months:
Nocturnal waking with wheezing, % 231(38.5%) -
.1 attack/per week, % 287 (47.8%) -
Admission or emergency, % 78 (13.0%) -
Mean (SD) periods between the first time chewing and
asthma diagnosed (yrs)
18.62614.49 -
Alcohol consumption (%)
No 500 (83.5%) 1002 (84.4%) 0.656
Yes 99 (16.6%) 185 (15.6%)
Smoking (%)
No 454 (75.9%) 932 (77.8%) 0.001
Yes 144 (24.1%) 189 (15.8%)
Betel chewing (%)
No 532 (88.7%) 1115 (92.9%) 0.003
Yes 68 (11.3%) 85 (7.1%)
Total IgE levels were logarithmically transformed before statistical testing to meet the assumption of a normal distribution.
doi:10.1371/journal.pone.0091889.t001
Table 2. The associations of the duration, amount and total life time consumption of betel chewing and asthma.
Betel chewing Total Males Females
Cases Controls p Cases Controls p Cases Controls p
Habit (%)
No 532(88.7%) 1115(92.9%) 0.001 192(75.3%) 426(83.5%) 0.02 340(98.6%) 689(99.9%) 0.031
Yes 68(11.3%) 85(7.1%) 63(24.7%) 84(9.6%) 5(1.5%) 1(0.1%)
Duration (%)
No 532(88.7%) 1115(92.9%) 0.01 192(75.3%) 426(83.5%) 0.02 340(98.6%) 689(99.9%) 0.02
1–15 years 36(6.0%) 45(3.8%) 33(11.8%) 45(8.8%) 3(0.9%) 0(0.0%)
.15 years 32(5.3%) 40(3.3%) 30(12.9%) 39(7.6%) 2(0.6%) 1(0.1%)
Mean (SD) age of
first chewing
21.767.8 23.467.9 0.23 21.767.9 22.066.2 0.83 - -
Mean (SD) lifetime,
pack6years
42.0660.1 35.9634.2 0.70 49.2663.6 35.9634.2 0.42 - -
Total life time exposure of betel chewing:one chewed pack corresponds to 10 betel quids.
doi:10.1371/journal.pone.0091889.t002
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Asthma is a chronic inflammatory disease that is mediated by a
number of chemokines. Eotaxin-1 belongs to the CC chemokine
family that attracts circulating Th2-lymphocytes and eosinophils
from the blood stream to the inflammatory foci. The expression of
eotaxin-1 protein and mRNA is significantly increased in the
epithelium of airway, proportional to eosinophil infiltration in
asthmatic patients [12]. One animal study has reported that smoke
increases the levels of eotaxin-1 expression under co-exposure to
other allergens, leading to airway inflammation [13]. In the
present study, we suggested that the mechanisms of exposure to
smoke and arecoline may implicate similar mechanisms of asthma
pathogenesis.
Therefore, we investigated the association between betel
chewing and asthma and investigated the role of arecoline and
eotaxin-1 in this association. We hypothesized that eotaxin-1
would play a mediating role in the association between betel
chewing and asthma and carried out a supplementary in vitro
experiment to study the functional associations between arecoline
exposure and eotaxin-1 levels. To our knowledge, this is the first
study to investigate the association between betel chewing,
eotaxin-1 concentrations and asthma and lung function.
Materials and Methods
Ethics Statement
This study was approved by the Institutional Review Board
(IRB) and performed in two medical centers in southern Taiwan:
Kaohsiung Medical University Hospital (KMUH) and Chang-
Gung Memorial Hospital (CGMH). These two hospitals provide
comprehensive medical services to patients of diverse socioeco-
nomic status in their geographic area. Informed written consent
was obtained from all subjects.
Case participants with asthma
We designed a case-control study and an in vitro experiment to
study the association between betel chewing, eotaxin-1 and asthma
and lung function. An enrollment system for cases was established
in the Division of Pulmonary and Critical Care Medicine of
CGMH and KMUH, so that patients with asthma could be
identified and offered to participate in a previous study [14]. In
our study, all of the patients received a pulmonary function test,
including bronchodilator testing. Patients were diagnosed as
having asthma if they had the following symptoms, episodic
breathlessness, cough, wheezing and chest tightness, according to
the Global Initiative for Asthma (GINA) guidelines, and/or they
demonstrated that at least a 12% and $200 ml increase in FEV1
from the pre-bronchodilator value by spirometry testing [15,16].
In this study, 693 adults with asthma who were more than 20 years
old were approached as outpatients of the Division of Pulmonary
and Critical Care Medicine at two medical centers. Of these 693
adults, 16 refused to participate (response rate 97.7%) and a
further 77 were excluded because they had emphysema, chronic
airway obstruction, tuberculosis, pneumonia or cancer (n = 62), or
incomplete data regarding their history of betel consumption
(n= 15). Therefore, a case sample of 600 (255 males and 345
females) was analyzed.
Control participants
In selecting the community control population, the basis for
selection was residence in the same geographic areas as the cases.
In the context of free health examinations, the community controls
were recruited at local health stations by advertising in five
communities. An expected sample size of 1500 people aged more
than 20 years old was approached, of whom 1428 agreed to
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participate (534 male, 894 female, response rate 95.2%). Of these,
a further 98 were excluded because of a previous history of
physician-diagnosed asthma, emphysema, chronic airway obstruc-
tion, tuberculosis, pneumonia or cancer (n = 78) or incomplete
data regarding betel consumption (n = 20). From a list of all
potential controls, the control participants were then matched by
age (65 year) and gender to cases in a ratio of 2 controls to 1 case.
Therefore, 1200 controls (510 males and 690 females) were
selected from the 1330 eligible participants on the basis of the most
recent recruitment.
The participants completed a questionnaire and underwent
lung function tests, the measurements of high-sensitivity C-
Reactive Protein (hs-CRP) and eotaxin-1, and evaluations of betel
chewing; some descriptions of these measurements are provided in
File S1.
Analysis of arecoline and arecaidine levels
A low prevalence of betel chewing was anticipated in Taiwanese
females, and indeed, only five females reported current betel
chewing in the present study. Therefore, we only selected male
current betel chewers (23 men with asthma and 35 male controls)
to investigate the arecoline and arecaidine levels. Of these, 2 cases
and 3 controls had insufficient plasma for arecoline and arecaidine
assays. Therefore, 21 males with asthma and 32 male controls with
current betel chewing were compared with respect to these levels.
We further selected 42 male asthma cases and 52 male controls
with no betel chewing by a 1:1-2 matching to case and control
betel users by age. Plasma specimens were stored at 270uC until
they were needed for use in the assays. A liquid chromatography–
tandem mass spectrometry (LC–MS–MS) analysis was used to
detect plasma arecoline and arecaidine as previously published [8].
Dermal and gingival fibroblast cultures
We obtained human normal dermal or gingival fibroblasts from
normal human skin specimens from routine skin and oral cavity
surgery, respectively. Dermal or gingival tissues were obtained and
cut to 1–2 mm3 and then incubated in a culture dish with
Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10%
Fetal bovine serum (FBS) for 7 days to harvest fibroblasts. The
third passage of human fibroblasts was seeded. We harvested the
dermal fibroblasts and stimulated them with IL-4 and TNF-alpha,
both of which were standard agents to induce the robust release of
eotaxin-1 from fibroblasts [17,18]. Fibroblasts were treated with
IL-4 (50 ng/ml) and TNF-alpha (100 ng/ml) (both from Pepro-
tech, Rock Hill, NJ) for 72 hours to induce eotaxin-1 release. Cells
were also pretreated with different concentrations of arecoline in
the first 24 hours where indicated. Each treatment condition was
assessed in triplicate in cells.
Statistical Analysis
The two groups were compared using x2 and t-tests to assess the
statistical significance. Because of the skewed distributions of IgE,
hs-CRP and eotaxin-1 levels, logarithmical transformations were
performed. To control for potential confounding effects, adjusted
odds ratios with 95% confidence intervals were calculated for each
risk factor using logistic regression. The Sobel-Goodman test was
used to test the mediation effect. One-way ANOVA and least
significant difference (LSD) multiple comparison tests were used to
compare arecoline and eotaxin-1 levels between the four groups of
male cases and controls with and without betel chewing, and
eotaxin-1 release was compared between cells treated with
different doses of arecoline. Spearman correlation coefficients
(R-values) were calculated to assess the associations between
arecoline, arecaidine, and lung function. The population attrib-
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utable fraction was estimated by the following formula: frequency
of betel chewing in the case group6 [(odds ratio–1)/odds ratio],
where the odds ratio for the effect of betel chewing on asthma was
estimated based on the multiple logistic regression model. We
performed statistical analyses using the software package SPSS
14.0.
Results
In unadjusted analyses (Table 1), the 600 case participants had
higher IgE levels compared to the control group. Alcohol
consumption behavior was not different between the two groups,
but smoking and betel chewing were more common in the case
group. In further unadjusted analyses (Table 2), the association
with current consumption was confirmed in both men and
women, and asthma was also associated with longer durations of
betel use, although not with the age of first use or use, as defined
by ‘pack x years’. Only three cases reported an age of first betel
chewing that was later than their reported age of asthma onset,
and the mean6SD period between first betel chewing and asthma
diagnosis was 18.6614.5 years.
In unadjusted analyses, therefore, BMI, smoking, betel chewing
and eotaxin-1 levels were associated with asthma. In logistic
regression analyses adjusting for the above potential confounding
factors (Table 3), the former and current use of betel chewing were
respectively associated with a 1.60- and 2.05-fold higher risk of
asthma than having never used it. The attributable risk of asthma
accounted for by betel chewing in the current or former use group
was estimated as 0.435 (0.77/1.77). The percentage of the
population attributable fraction was 4.9% ([68/600]60.45) for
all adult asthma, 11.7% for male asthma and 1.2% for female
asthma. If eotaxin-1 was further included in the multiple logistic
regression analysis, the association between current betel chewing
and asthma was attenuated and not significant. Testing whether
eotaxin-1 mediated the association between betel chewing to
asthma, we found a Sobel-Goodman coefficient of 0.08 (p,0.001).
Both a model with asthma regressed on betel chewing (p,0.001)
and a model with log eotaxin-1 (mediator) regressed on betel
chewing (p,0.001) were statistically significant. Furthermore,
multiple regression with asthma regressed on log eotaxin-1
(mediator) and betel chewing was only significant for log
eotaxin-1 (p,0.001), but the significance for betel chewing
weakened (p = 0.045). The mediation effect of eotaxin-1 was
significant, with approximately 50.5% of the total effect of betel
chewing on asthma mediated through this pathway.
In Table 4, four groups of male participants are compared
according to the presence of asthma and current betel chewing
after adjusting for potential confounding factors. Within the case
group, arecoline, arecaidine, eotaxin-1 levels, FEV1 and FVC
were significantly higher in people reporting current betel
chewing. However, no associations were found between betel
chewing and levels of leptin, transforming growth factor b1 (TGF-
b1), or hs-CRP in asthmatics. In Table 5, a higher arecoline level
was associated with higher eotaxin-1 levels and also associated
with worse respiratory function in asthmatics. Higher arecaidine
levels were only associated with a worse respiratory function in the
case group.
To investigate the functional associations between arecoline
exposure and eotaxin-1 levels, we harvested fibroblasts with or
without stimulations with IL-4 and TNF-alpha for 72 hours and
measured eotaxin-1 in the conditioned medium. We found that
treatment with arecoline alone at tested concentrations of 0, 10,
25, 100 and 200 mg/ml induced very little eotaxin-1 release (from
060 pg/ml to 2362 pg/ml of eotaxin-1 for any tested dose of
arecoline). However, we found that pretreatment with arecoline at
100 mg/ml induced a significant elevation of eotaxin-1 levels
(2700698 pg/ml, p = 0.01 by Bonferroni multiple correction tests)
compared with the pretreatment of arecoline at 0 mg/ml
(18506142 pg/ml) under the TNF-alpha and IL-4 stimulations.
A drop in eotaxin-1 level (18986132 pg/ml) was noticed in
stimulated fibroblasts treated with 200 mg/ml arecoline (Figure 1).
Because the exposure to betel chewing directly interacts with the
oral mucosa but not the skin, we harvested gingival fibroblasts and
Table 5. Correlation of arecoline and arecaidine levels with
eotaxin-1 levels and lung function in male asthmatics.
Male asthma
Arecoline Arecaidine
r* p-value r* p-value
Eotaxin-1 0.303 0.02* 0.162 0.23
FEV1, % pred 20.359 0.004* 20.370 0.003*
FVC, % pred 20.309 0.02* 20.303 0.02*
IgE 0.103 0.43 20.129 0.32
hs-CRP 0.042 0.78 0.060 0.68
Leptin 0.012 0.93 0.218 0.09
TGF-b1 20.084 0.52 20.145 0.26
*Spearman correlation coefficient.
Arecoline, arecaidine, IgE, hs-CRP, leptin, TGF-b1 and eotaxin-1 levels were
logarithmically transformed before statistical testing to meet the assumption of
normal distribution.
doi:10.1371/journal.pone.0091889.t005
Figure 1. In cultured dermal fibroblast cells, the levels of
eotaxin-1 were measured by ELISA in supernatants from cells
treated with different levels of arecoline (0, 10, 25, 100, and
200 mg/ml for 24 h). The levels of eotaxin-1 (mean6SD) were
analyzed by one-way ANOVA and Bonferroni multiple correction tests
in which the P values are adjusted by multiplying by 10. * p = 0.01035
for the pretreatment of arecoline at 100 mg/ml induced significant
elevation of eotaxin-1 levels (2700698 pg/ml) compared with the
pretreatment of arecoline at 0 mg/ml (18506142 pg/ml) under the TNF-
alpha and IL-4 stimulations. Arecoline increased cytotoxicity with more
than 45% at a concentration of 200 mg/ml [22]. The stimulated groups
indicate that the fibroblast cells were treated with IL-4 (50 ng/ml) and
TNF-alpha (100 ng/ml) for 72 hours. The baseline groups are fibroblast
cells that were treated with arecoline alone, not stimulated with IL-4
and TNF-alpha.
doi:10.1371/journal.pone.0091889.g001
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repeated the above experiment to consolidate the cause-relation-
ship. We also found that treatment with arecoline alone at any
tested concentration from 0 to 200 mg/ml did not induce an
eotaxin-1 release (060 pg/ml for any tested dose of arecoline). In
the presence of TNF-alpha and IL-4, the pretreatment of arecoline
at 100 mg/ml induced a significant elevation of eotaxin-1
expression (1489678 pg/ml) compared with the retreatment of
arecoline at 0 mg/ml (1044695 pg/ml, p = 0.03) from stimulated
gingival fibroblasts (Figure 2).
Discussion
To date, few epidemiological studies have investigated the
potential effect of betel chewing on the susceptibility to asthma and
impairment of lung function, and these studies have suffered from
relatively small sample sizes [10,19]. The underlying mechanism
that drives the proposed relationship between betel chewing and
asthma is also still unclear. A causal role of betel chewing on
asthma risk is supported by a strong relationship of this exposure
as well as exposure to arecoline and eotaxin-1 with asthma, both in
our large case-control study and in a supplementary in vitro
experiment. There are several novel findings in the present study.
The first is that the arecoline levels were positively correlated with
eotaxin-1 concentrations and negatively correlated with lung
function in male cases. Second, current betel chewing was
associated with asthma, but this association was attenuated after
adjustment for eotaxin-1 concentrations. Third, the functional
connection between arecoline exposure and eotaxin-1 release was
supported by the in vitro experiment. Therefore, our findings
support an effect of betel chewing on asthma that is mediated at
least in part by eotaxin-1.
In a previous double blind challenge study, the concentration of
arecoline that caused a 20% reduction in FEV1 (PC20) in
asthmatic patients was 5.2 mg/ml, and the PC20 value was only
1.6 mg/ml for methacholine, which exerted a stronger effect than
arecoline [10]. A skin prick test in patients with a respiratory
allergy showed a 38.6% positivity against areca pollen, and this
was significantly associated with emergency asthma hospitalization
[19]. Tracheal contraction to both histamine and arecoline
increased significantly in ovalbumin-aerosol exposed animals
[20], and was enhanced by 155% compared to saline-aerosol
exposed animals [21]. In our study, current betel chewing
increased the risk of asthma, and the levels of arecoline and
arecaidine were negatively correlated with FEV1 and FVC
measures of respiratory function in male asthmatic patients.
Therefore, the present study is consistent with previous findings.
To our knowledge, ours is the first study to investigate the
relationship between the levels of arecoline, asthma and eotaxin-1.
We demonstrated that the levels of arecoline were positively
correlated with eotaxin-1 in vivo and that eotaxin-1 release could be
stimulated significantly by pretreatment with arecoline at 100 mg/
ml in the presence of IL-4 and TNF-alpha. A notable pathological
atrophy of cell morphology was found with arecoline concentra-
tions of 100 mg/ml, which is consistent with a previous study that
also suggested that the effective concentration of arecoline was
approximately 100 mg/ml [22]. Eotaxin-1 is a chemokine that can
regulate nuclear factor kappa B (NF-kB) and is stimulated by
cytokines and oxidant stress [23,24]. Hydroxyl radicals, superox-
ide radicals and H2O2 are found in the gas phase of environmental
tobacco smoke (ETS) [25] and are also formed while chewing betel
quid [26]. Reactive oxygen species (ROS) are known to activate
regulators of eotaxin-1 expression, such as NF-kB [27]. NF-kB
activation and ROS genesis have both been found to be induced
by areca nut extract; therefore, the NF-kB activation may be the
basis of the ROS genesis [28]. Several animal studies have
reported that smoke and environmental tobacco smoke increase
the levels of eotaxin-1 expression and allergen-induced airway
remodeling [29,13]. Therefore, we suggest that the mechanisms of
exposure to ETS and arecoline may implicate similar mechanisms
of asthma pathogenesis.
Our in vitro study found that treatment with arecoline alone by
dermal and gingival fibroblasts at any concentration did not
induce eotaxin-1 release. However, after stimulation with IL-4 and
TNF-alpha, both of which are standard agents to induce robust
release of eotaxin-1 from fibroblasts [17,18], pretreatment with
arecoline at 25 and 100 mg/ml induced a significant elevation of
eotaxin-1, suggesting that under proinflammatory circumstances,
arecoline can induce eotaxin-1 release and modify the disease
process in asthma. Similar to our study, mice exposed to chronic
ETS alone did not develop significant airway inflammation, but
co-exposure to a combination of ETS and OVA allergen induced
increased expression of eotaxin-1 compared with exposure to
either chronic ETS or chronic OVA allergen alone [29]. In our
study, a drop in the eotaxin-1 level was noticed in stimulated
fibroblasts treated with 200 mg/ml arecoline compared with the
pretreatment of arecoline at 100 mg/ml (Figure 1 and 2), which
may be caused by the toxicity of arecoline to fibroblasts in vitro.
Our previous cytotoxic assay of arecoline found a more than 45%
increase of cytotoxicity with arecoline treatments at a concentra-
tion of 200 mg/ml [22].
Figure 2. In cultured gingival fibroblast cells, the levels of
eotaxin-1 were measured by ELISA in supernatants from cells
treated with different levels of arecoline (0, 10, 25, 100, and
200 mg/ml for 24 h). The levels of eotaxin-1 (mean6SD) were
analyzed by one-way ANOVA and Bonferroni multiple correction tests
in which the P values are adjusted by multiplying by 10. * p = 0.03301
for the pretreatment of arecoline at 100 mg/ml induced significant
elevation of eotaxin-1 levels (1489678 pg/ml) compared with the
pretreatment of arecoline at 0 mg/ml (1044695 pg/ml) under TNF-
alpha and IL-4 stimulation. Arecoline, at a concentration of 200 mg/ml,
increased cytotoxicity by more than 45% [22]. The stimulated groups
indicate that the fibroblast cells were treated with IL-4 (50 ng/ml) and
TNF-alpha (100 ng/ml) for 72 hours. The baseline groups are fibroblast
cells that were treated with arecoline alone, not stimulated with IL-4
and TNF-alpha. Arecoline alone at any tested concentrations from 0 to
200 mg/ml cannot induce detectable eotaxin-1 release (060 pg/ml for
any tested dose of arecoline).
doi:10.1371/journal.pone.0091889.g002
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Strength and limitations of study
There are several noteworthy strengths in the present study.
First, we applied an epidemiological study to test the primary
hypothesized relationship between betel chewing and asthma as
well as to investigate whether eotaxin-1 levels explain the
association of betel chewing with asthma, which was supplemented
by an in vitro experiment to demonstrate the functional link
between arecoline pretreatment and a significant elevation of
eotaxin-1 using cultured cell lines of both human normal dermal
and gingival fibroblasts. Dermal fibroblasts are a potent source of
human eotaxin-1 [30]. Second, a temporal relationship between
betel chewing as an exposure and asthma as an outcome was
supported because the mean6SD age of first reported betel
chewing in asthma patients was 21.767.8 years compared to a
mean6SD age of first asthma diagnosis of 44.9618.2 years. Only
three cases reported the latter to be earlier than the former, and
most reported a long period of prior betel exposure. Third, logistic
regression models were used to control for potential confounding
factors, including age, BMI, smoking and betel chewing, which
were associated with the case status, consistent with reports from
previous studies. Fourth, although the measurement of betel
chewing was based on self-reported information with the attendant
risk of recall bias, arecoline and arecaidine were also significantly
higher in people reporting current betel chewing in asthma and
the control groups in this study. We have previously found that
plasma arecoline and arecaidine levels are measurable and good
biomarkers for recent betel use [8], thereby improving the
exposure ascertainment in this respect.
Several limitations of this study should be considered. The first
limitation is a very low prevalence of betel chewing in Taiwanese
females, as previously reported [31], leading to a difficultly in
investigating the association with asthma in females, although case
control differences were confirmed in women in unadjusted
analyses. Second, it was difficult to obtain direct information on
past arecoline exposure from a case control study; hence, we only
evaluated the arecoline exposure for current chewers and not for
former chewers. However, we analyzed the associations between
former betel chewing and asthma, and these were consistent with,
although weaker than, those with current chewing (Table 3). In
sum, we do not believe that inaccurate or biased recall accounted
for the observed associations. In this study, our results suggest a
population attributable fraction for betel chewing on asthma of
11.7% for males and 1.2% for females, and our findings strongly
implicate a relationship between arecoline levels and eotaxin-1
concentrations, providing further evidence for a major role for
eotaxin-1 in linking betel chewing with asthma.
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